← SynDRA
ORE-1001
SynDRA canonical compound SYN0008563 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | ACE2 |
| Mechanism of action | angiotensin converting enzyme inhibitor |
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- ACE2 INHIBITOR
Cross-references
Synonyms
- Gl-1001
- ORE1001
- GL1001
- MLN-4760
- ORE-1001 FREE ACID
- MLN 4760
- UNII-4LD0ZHV25K
- 4LD0ZHV25K
- CHEMBL429844
- (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}-4-METHYL-PENTANOIC ACID
- XX5
- N-[(1s)-1-carboxy-3-methylbutyl]-3-(3,5-dichlorobenzyl)-l-histidine
- (2S)-2-[[(2S)-3-[3-[(3,5-dichlorophenyl)methyl]imidazol-4-yl]-1-hydroxy-1-oxopropan-2-yl]amino]-4-methylpentanoic acid
- AC1L9LSK
- GTPL7866
- SCHEMBL1691048
- BDBM21489
- DTXSID70184609
- ZINC1549629
- DB12271
- HY-19414
- CS-0015513
- Mln-4760
- MLN4760
- GL-1001
- CHEBI:166834
- RefChem:819031
- DTXCID60107100
- C19H23Cl2N3O4
- orb1308021
- GLXC-03260
- EX-A3296
- EBC-44366
- MLN-4760?
- s8940
- AKOS040742161
- DA-75631
- MS-27570
Look up ORE-1001 in the interactive SynDRA portal →